Article Details

Interleukin-6 Receptor Antagonists Improve Outcomes in Severe COVID-19

Retrieved on: 2021-02-25 23:03:45

Tags for this article:

Click the tags to see associated articles and topics

Interleukin-6 Receptor Antagonists Improve Outcomes in Severe COVID-19. View article details on hiswai:

Excerpt

Tocilizumab and sarilumab are both monoclonal antibodies and work by inhibiting membrane-bound and soluble IL-6 receptors. They are used to ...

Article found on: www.contagionlive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up